Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis

BACKGROUND: Neoadjuvant chemotherapy (NAC) increases breast conservation rates in patients with resectable breast cancer at the associated cost of higher locoregional recurrence rates; however, the magnitude of the survival benefits of NAC for these patients remains undefined. Therefore, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan, Shi, Xiu-E, Tian, Jin-Hui, Yang, Xu-Juan, Wang, Yong-Feng, Yang, Ke-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976345/
https://www.ncbi.nlm.nih.gov/pubmed/29768327
http://dx.doi.org/10.1097/MD.0000000000010634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976345/
https://www.ncbi.nlm.nih.gov/pubmed/29768327
http://dx.doi.org/10.1097/MD.0000000000010634

Ejemplares similares